Implantable cardiac defibrillators for patients with non-ischaemic cardiomyopathy

The efficiency of using KardiaMobile 6L in the cardiac electrophysiology clinic

“…Future research should focus on larger, randomized trials to validate these findings and explore the long‐term benefits and potential limitations of KardiaMobile 6‐lead ECG in diverse clinical environments. Furthermore, investigating the use of KardiaMobile 6‐lead ECG in specific patient populations, such as those with complex arrhythmias or comorbidities associated with arrhythmias such as cardiomyopathies and heart failure, could provide additional insights into its clinical utility 9,10 . The development of guidelines and protocols for integrating KardiaMobile 6‐lead ECG into routine practice will be essential to maximize its benefits and ensure patient safety.…”

The utility of the Florida Shock Anxiety Scale: What have we learned?

“…Cardiac implantable electronic devices are an essential cornerstone of medical practice . Implantable cardioverter‐defibrillators (ICDs), when used in individuals with clinical indications, are cost‐effective . Nonetheless, this benefit does not come without psychological inconveniences in some patients.…”

“…1-4 Implantable cardioverter-defibrillators (ICDs), when used in individuals with clinical indications, are cost-effective. 1,5 Nonetheless, this benefit does not come without psychological inconveniences in some patients. Numerous studies investigated these inconveniences which include shock anxiety, depression, poor device acceptance, and impaired quality of life.We need further research to quantify the effect of different management strategies on shock anxiety across the FSAS.…”